ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,201 | 41.26199 | 0 | male | 0 | 25 | 624 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | $25-$50k | 0 | 71,995 | 42,603.4375 | 44,057 | 21.75 | black | 17 | 28 | 0.908936 | 0.875977 | 6 | 0 | 0 | no | null | null | no dnr | 25 | 45 | 19 | 125 | 14 | 39.09375 | 77 | null | 0.799927 | 0.899902 | 131 | 7.319336 | 346 | 18 | 2,912 | null | 0 | no(M2 and SIP pres) | 0 |
5,202 | 69.25397 | 1 | male | 0 | 23 | 105 | MOSF w/Malig | ARF/MOSF | 2 | 9 | under $11k | 9 | 85,837 | 48,802.375 | 52,449 | 19 | white | 28.5 | 47 | 0.438965 | 0.319946 | 13 | 1 | 0 | yes | 0.6 | 0.3 | no dnr | 23 | 71 | 6.299805 | 104 | 22 | 36.39844 | null | 1.099854 | 2.099609 | 1.899902 | 137 | null | 167 | 117 | 1,725 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,203 | 20.767 | 1 | female | 1 | 121 | 121 | MOSF w/Malig | ARF/MOSF | 1 | 14 | under $11k | 0 | 314,505 | null | null | 16.25 | white | 25.898438 | 26 | 0.540894 | 0.426941 | 46 | 0 | 0 | metastatic | 0.7 | 0.5 | dnr after sadm | 121 | 83 | 12.5 | 76 | 16 | 36.29688 | null | 3.899902 | 0.699951 | 1.399902 | 135 | null | 68 | 23 | null | 5 | 4 | no(M2 and SIP pres) | 4 |
5,204 | 55.29398 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 61 | 25,610 | 14,894.8516 | 14,287 | 32 | white | 27.5 | 52 | 0.511963 | 0.395996 | 4 | 0 | 0 | no | 0.5 | 0.25 | dnr after sadm | 3 | 80 | 7.699219 | 110 | 12 | 36.79688 | 177.5 | 2.399902 | null | 0.799927 | 136 | 7.399414 | 141 | 11 | 2,430 | null | null | <2 mo. follow-up | 2.475586 |
5,205 | 32.62399 | 0 | male | 0 | 5 | 622 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 9,490 | 5,901.4141 | 5,805 | 17 | black | 20 | 28 | 0.929932 | 0.880981 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 70 | 5.399414 | 72 | 24 | 36.69531 | 459.25 | null | 0.5 | 1.299805 | 135 | 7.429688 | 62 | 24 | 850 | 0 | 0 | null | 0 |
5,206 | 62.5 | 1 | male | 1 | 5 | 5 | Coma | Coma | 0 | 3 | under $11k | 100 | 28,348 | null | null | 37 | black | 36.195313 | 71 | 0.018997 | 0.007999 | 1 | 0 | 0 | no | 0.1 | 0.5 | dnr after sadm | 4 | 113 | 6.299805 | 193 | 32 | 36.29688 | 118.35938 | null | null | 0.699951 | 135 | 7.399414 | 195 | 21 | 3,700 | null | 7 | <2 mo. follow-up | 7 |
5,207 | 44.52597 | 1 | male | 0 | 50 | 165 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | under $11k | 0 | 122,325 | 73,861.4375 | 75,465 | 24.75 | black | 31.097656 | 27 | 0.562988 | 0.450989 | 16 | 0 | 0 | metastatic | 0.3 | 0.2 | no dnr | 50 | 55 | 6.399414 | 67 | 20 | 36.5 | null | null | 0.799927 | 1 | 140 | null | 87 | 29 | 2,475 | null | 0 | no(M2 and SIP pres) | 0 |
5,208 | 52.82098 | 1 | female | 0 | 5 | 153 | Colon Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 5,884 | 3,786.0137 | 3,873 | 13 | white | 20.699219 | 15 | 0.78894 | 0.554932 | 1 | 1 | 0 | metastatic | 0.9 | 0.95 | no dnr | 5 | 147 | 0.199982 | 135 | 30 | 35.79688 | 412 | 2.599609 | 11.898438 | 2.599609 | 142 | 7.399414 | 164 | 105 | 2,060 | 1 | 2 | no(M2 and SIP pres) | 2 |
5,209 | 42.41998 | 0 | female | 0 | 16 | 621 | COPD | COPD/CHF/Cirrhosis | 1 | 18 | $25-$50k | 0 | 21,687 | 14,074.9141 | 15,533 | 9.666664 | black | 20.597656 | 26 | 0.932983 | 0.885986 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 16 | 113 | 18.597656 | 92 | 20 | 36.59375 | 242.84375 | null | null | 7 | 138 | 7.149414 | 200 | 67 | null | 0 | null | no(M2 and SIP pres) | 0.494751 |
5,210 | 65.36096 | 1 | male | 0 | 6 | 265 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | >$50k | 0 | 10,511 | 6,464.8906 | 8,346 | 12 | white | 23.398438 | 30 | 0.820923 | 0.708984 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 6 | 77 | 8.599609 | 60 | 36 | 38.19531 | 185.6875 | 2.899902 | 1.299805 | 2.199707 | 134 | 7.399414 | 356 | 70 | 1,200 | 1 | 3 | no(M2 and SIP pres) | 3 |
5,211 | 41.58197 | 0 | male | 0 | 9 | 620 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 36,979 | null | null | 20 | white | 29 | 44 | 0.784912 | 0.714966 | 4 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 9 | 109 | 6.799805 | 95 | 16 | 36.39844 | null | 2.099609 | 0.299988 | 1.099854 | 137 | null | 97 | 17 | null | null | null | null | 2.427246 |
5,212 | 85.185 | 1 | female | 1 | 3 | 3 | Coma | Coma | 0 | 16 | null | 100 | null | null | null | 33 | white | 69.296875 | 58 | 0 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 53 | 14.298828 | 125 | 30 | 38.79688 | 130 | null | null | 1.399902 | 138 | 7.40918 | 106 | 27 | 2,730 | null | null | <2 mo. follow-up | 2.15918 |
5,213 | 72.20795 | 1 | male | 1 | 9 | 9 | Coma | Coma | 0 | null | null | 100 | 57,252 | null | null | 34 | white | 18.898438 | 31 | 0.209991 | 0.14798 | 5 | 0 | 0 | no | null | null | dnr after sadm | 3 | 68 | null | 65 | 16 | 35.79688 | null | null | 0.699951 | 1.399902 | 140 | null | 122 | 20 | 3,350 | null | null | <2 mo. follow-up | 2.241699 |
5,214 | 41.06998 | 1 | female | 1 | 4 | 4 | Coma | Coma | 2 | null | null | 100 | 45,291 | null | null | 22 | white | 40.898438 | 74 | 0.011 | 0.004 | 23 | 1 | 0 | no | null | null | dnr after sadm | 1 | 89.5 | 17.097656 | 115 | 24 | 36.5 | 228.96875 | null | null | 2.099609 | 148 | 7.399414 | 103 | 86 | 4,665 | null | null | <2 mo. follow-up | 2.875977 |
5,215 | 64.83197 | 1 | male | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 8 | null | 0 | 49,863 | null | null | 46.5 | white | 32.59375 | 57 | 0.350952 | 0.233978 | 3 | 0 | 0 | metastatic | 0.3 | 0.1 | dnr after sadm | 8 | 68 | 6.5 | 65 | 12 | 35.5 | 215 | null | 0.399963 | 0.699951 | 152 | 7.489258 | 222 | 10 | 1,190 | null | 6 | <2 mo. follow-up | 6 |
5,216 | 47.44397 | 0 | female | 0 | 20 | 619 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 24,405 | 15,665.9922 | 15,470 | 15 | white | 15.298828 | 6 | 0.947998 | 0.909912 | 1 | 0 | 0 | no | null | null | no dnr | 20 | 79 | 13.099609 | 104 | 20 | 38.5 | null | 3.799805 | 0.599976 | 0.599976 | 138 | null | 106 | 4 | 4,700 | 0 | 4 | no(M2 and SIP pres) | 4 |
5,217 | 79.69598 | 1 | female | 0 | 57 | 185 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 44 | null | 103,971.5 | 108,941 | 36.25 | white | 21.199219 | 44 | 0.571899 | 0.460999 | 9 | 0 | 0 | no | 0.75 | 0.7 | no dnr | 57 | 75 | 5.199219 | 75 | 18 | 38.29688 | null | null | 0.599976 | 1.299805 | 140 | null | 153 | 11 | 1,160 | null | 5 | adl>=4 (>=5 if sur) | 5 |
5,218 | 45.16397 | 1 | female | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 83,679 | 48,635.375 | 46,222 | 33.333313 | black | 28.5 | 37 | 0.44696 | 0.327942 | 13 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 68 | 11.898438 | 65 | 10 | 39 | 300 | null | null | 1.099854 | 135 | 7.489258 | 205 | 21 | 2,765 | null | null | <2 mo. follow-up | 2.408203 |
5,219 | 56.03 | 1 | male | 0 | 19 | 505 | MOSF w/Malig | ARF/MOSF | 2 | 16 | >$50k | 0 | 34,500 | 20,821.2969 | 24,586 | 13 | white | 22.898438 | 17 | 0.711914 | 0.625 | 2 | 0 | 0 | yes | 0.6 | 0.4 | no dnr | 19 | 128 | 13.099609 | 65 | 11 | 38.09375 | 285.6875 | 2.799805 | null | 1.599854 | 136 | 7.439453 | 148 | 30 | 663 | 1 | null | no(M2 and SIP pres) | 1.166748 |
5,220 | 61.56598 | 1 | female | 1 | 339 | 339 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 44 | 1,016,214 | null | null | 42 | white | 34.296875 | 63 | 0.304993 | 0.192993 | 13 | 0 | 0 | no | null | null | dnr after sadm | 186 | 131 | 6 | 62 | 24 | 37.69531 | 366.625 | 3.799805 | 0.799927 | 0.599976 | 140 | 7.439453 | 137 | 7 | 2,000 | null | null | adl>=4 (>=5 if sur) | 2.867676 |
5,221 | 75.85498 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | $11-$25k | 94 | 63,978 | null | null | 43 | white | 33.398438 | 66 | 0.112991 | 0.048996 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 6 | 73 | 11.898438 | 150 | 16 | 38.59375 | 61.66406 | 2.099609 | null | 0.899902 | 140 | 7.349609 | 113 | 18 | 3,500 | null | 1 | <2 mo. follow-up | 1 |
5,222 | 57.17999 | 0 | female | 0 | 5 | 617 | CHF | COPD/CHF/Cirrhosis | 3 | 17 | under $11k | 9 | 4,719 | 3,361.4668 | 3,103 | 6 | white | 17.097656 | 11 | 0.893921 | 0.821899 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 98 | 23 | 115 | 12 | 36.69531 | 187.5 | 1.099854 | 3.299805 | 1.399902 | 144 | 7.40918 | 78 | 43 | 1,480 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,223 | 68.68195 | 0 | male | 0 | 20 | 616 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 37 | 68,006 | 41,975.4062 | 43,296 | 28.666656 | white | 27.199219 | 41 | 0.54895 | 0.434998 | 4 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 20 | 57 | 10.298828 | 75 | 16 | 35 | 368 | null | 0.299988 | 0.5 | 135 | 7.459961 | 104 | 13 | 490 | null | 0 | no(M2 and SIP pres) | 0 |
5,224 | 38.56299 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 34,125 | 18,525.8594 | 15,510 | 47 | null | 95.59375 | 129 | 0 | 0 | 3 | 0 | 0 | no | 0.1 | 0.05 | dnr after sadm | 3 | 65 | 6.5 | 55 | 16 | 36.5 | 177.5 | null | null | 1.199951 | 137 | 7.459961 | 152 | 33 | 1,400 | null | null | <2 mo. follow-up | 1.051758 |
5,225 | 69.71899 | 1 | male | 0 | 5 | 68 | Lung Cancer | Cancer | 4 | 3 | under $11k | 0 | 4,335 | null | null | 8 | white | 22.699219 | 19 | 0.563965 | 0.241974 | 1 | 1 | 0 | metastatic | null | null | no dnr | 5 | 108 | 25.296875 | 70 | 12 | 36.29688 | 287.5 | null | 14.898438 | 7.399414 | 140 | 7.359375 | 77 | 83 | 1,975 | null | 0 | null | 0 |
5,226 | 58.793 | 0 | male | 0 | 11 | 616 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | $25-$50k | 0 | 26,940 | 14,998.5781 | 15,549 | 30.5 | white | 26.199219 | 47 | 0.806885 | 0.687988 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 55 | 16.296875 | 135 | 24 | 38 | 72.5 | null | 2.299805 | 1.5 | 137 | 7.319336 | 74 | 20 | 2,220 | null | 0 | no(M2 and SIP pres) | 0 |
5,227 | 75.93695 | 1 | male | 0 | 13 | 143 | COPD | COPD/CHF/Cirrhosis | 3 | 15 | $11-$25k | 0 | 13,997 | 9,179.1484 | 10,873 | 8 | white | 17.699219 | 37 | 0.751953 | 0.608887 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 13 | 100 | 4.699219 | 104 | 26 | 36 | 454.125 | 1.5 | 0.599976 | 5.699219 | 136 | 7.569336 | 165 | 35 | 675 | 2 | 4 | adl>=4 (>=5 if sur) | 4 |
5,228 | 64.85699 | 1 | male | 0 | 4 | 536 | Colon Cancer | Cancer | 2 | null | null | 0 | 10,381 | 6,016.0352 | 5,439 | 7 | white | 14.599609 | 5 | 0.846924 | 0.661987 | 1 | 1 | 0 | metastatic | 0.8 | 0.5 | no dnr | 4 | 73 | 10.5 | 65 | 32 | 38.59375 | 208.5625 | 2.899902 | 0.5 | 1.699951 | 135 | 7.389648 | 242 | 34 | 3,062 | null | null | null | 1.786621 |
5,229 | 62.41199 | 1 | male | 0 | 4 | 183 | CHF | COPD/CHF/Cirrhosis | 6 | 12 | $11-$25k | 0 | 3,217 | 2,380.4453 | 2,369 | 13 | black | 16.296875 | 11 | 0.900879 | 0.833984 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 4 | 47 | 29.699219 | 125 | 42 | 38.79688 | 161.65625 | null | 0.399963 | 1.299805 | 146 | 7.389648 | 376 | 81 | 1,277 | 2 | 2 | adl>=4 (>=5 if sur) | 2 |
5,230 | 65.64294 | 1 | male | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $25-$50k | 44 | 205,473 | 118,190.562 | 110,383 | 48.25 | white | 34.195313 | 80 | 0.394958 | 0.27594 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 35 | 72 | 8.599609 | 60 | 12 | 35.69531 | 223.78125 | null | 1.5 | 1.899902 | 143 | 7.419922 | 121 | 38 | 2,365 | null | 0 | <2 mo. follow-up | 0 |
5,231 | 74.42297 | 1 | female | 0 | 112 | 174 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | under $11k | 26 | 235,109 | null | null | 27.5 | white | 26.296875 | 34 | 0.61499 | 0.509888 | 2 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 112 | 103 | 5.799805 | 84 | 20 | 36.09375 | null | 3.599609 | 1.299805 | 0.799927 | 146 | null | 88 | 14 | 2,710 | null | 0 | adl>=4 (>=5 if sur) | 0 |
5,232 | 50.63397 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 50,165 | 31,491.5781 | 30,715 | 55.5 | black | 43.695313 | 93 | 0.447998 | 0.328979 | 1 | 0 | 0 | no | 0.1 | 0.1 | dnr after sadm | 9 | 47 | 8.398438 | 60 | 32 | 36.59375 | 162.5 | null | 0.299988 | 0.799927 | 136 | 7.369141 | 128 | 28 | 1,690 | null | 0 | <2 mo. follow-up | 0 |
5,233 | 50.37399 | 1 | female | 0 | 9 | 182 | Colon Cancer | Cancer | 2 | 12 | >$50k | 0 | 9,406 | 6,254.0508 | 6,597 | 8 | white | 20 | 19 | 0.802979 | 0.580933 | 1 | 1 | 0 | metastatic | 0.8 | 0.6 | no dnr | 9 | 123 | 14.5 | 115 | 28 | 37.79688 | 366.625 | null | null | 1.099854 | 136 | 7.459961 | 259 | 25 | 3,820 | 1 | 0 | no(M2 and SIP pres) | 0 |
5,234 | 41.125 | 0 | male | 0 | 12 | 612 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 59,788 | 34,637.9688 | 41,609 | 29 | white | 27.5 | 28 | 0.823975 | 0.764893 | 2 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 12 | 75 | 15.298828 | 115 | 28 | 38.19531 | 250 | 2.299805 | 4.399414 | 0.799927 | 146 | 7.449219 | 109 | 29 | 3,250 | 0 | 0 | null | 0 |
5,235 | 50.237 | 1 | male | 0 | 4 | 199 | Lung Cancer | Cancer | 1 | 16 | >$50k | 0 | 10,702 | 5,278.9219 | 3,583 | 14 | white | 16.699219 | 13 | 0.745972 | 0.483948 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 4 | 103 | 4.399414 | 80 | 20 | 36.29688 | null | null | 0.5 | 1 | 135 | null | 89 | 16 | null | 0 | null | null | 0.494751 |
5,236 | 65.67798 | 1 | female | 0 | 4 | 432 | Lung Cancer | Cancer | 1 | null | null | 0 | 10,072 | 5,396.9336 | 4,051 | 12 | white | 15.898438 | 17 | 0.727905 | 0.454956 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 4 | 95 | 10.898438 | 136 | 20 | 36.69531 | 348 | null | 0.699951 | 0.699951 | 138 | 7.439453 | 109 | 12 | null | null | null | null | 2.665527 |
5,237 | 78.64996 | 1 | female | 1 | 5 | 5 | Coma | Coma | 0 | 4 | $11-$25k | 100 | 15,947 | 9,404.7422 | 8,190 | 35 | white | 26.398438 | 58 | 0.059998 | 0.031998 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 105 | 7.799805 | 55 | 12 | 38.79688 | 202.5 | null | 0.599976 | 2.599609 | 133 | 7.459961 | 258 | 66 | 5,620 | null | 2 | <2 mo. follow-up | 2 |
5,238 | 54.33798 | 1 | male | 0 | 11 | 141 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 14,277 | 9,446.7812 | 9,115 | 16 | black | 24.199219 | 31 | 0.756958 | 0.61499 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 11 | 79 | 12.099609 | 49 | 24 | 36.5 | 597.125 | null | 0.299988 | 1 | 139 | 7.319336 | 189 | 31 | null | 4 | 3 | no(M2 and SIP pres) | 3 |
5,239 | 45.37997 | 1 | female | 0 | 21 | 97 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 35,444 | 22,814.7031 | 23,440 | 26.666656 | other | 24.597656 | 45 | 0.85791 | 0.807983 | 1 | 1 | 0 | no | 0.85 | 0.7 | no dnr | 21 | 49 | 7.5 | 62 | 28 | 35.29688 | null | 3.599609 | 1.299805 | 1.699951 | 130 | null | 76 | 43 | 2,900 | 6 | 4 | null | 4 |
5,240 | 58.34598 | 1 | male | 1 | 17 | 17 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $11-$25k | 100 | 33,035 | 20,674.2188 | 20,585 | 27.666656 | white | 43.796875 | 96 | 0.001 | 0 | 1 | 0 | 0 | yes | 0.25 | 0.15 | dnr after sadm | 1 | 107 | 8.599609 | 74 | 16 | 35.39844 | null | null | 0.5 | 1.899902 | 145 | null | 212 | 29 | 2,350 | null | 1 | <2 mo. follow-up | 1 |
5,241 | 52.86499 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 100 | 32,148 | 19,020.4219 | 18,085 | 19 | black | 22.699219 | 38 | 0.131989 | 0.060997 | 6 | 0 | 0 | metastatic | 0.1 | 0 | dnr before sadm | -3 | 138 | 28.5 | 145 | 10 | 38.79688 | 236 | 2.099609 | 15.199219 | 1 | 140 | 7.439453 | 136 | 30 | 3,540 | null | null | <2 mo. follow-up | 4.486328 |
5,242 | 70.85596 | 0 | male | 0 | 14 | 610 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | null | 0 | 29,607 | 19,447.8281 | 20,150 | 10.333328 | white | 26.398438 | 38 | 0.688965 | 0.596924 | 1 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 14 | 60 | 11.898438 | 65 | 30 | 38 | 272 | 4 | 0.399963 | 0.599976 | 124 | 7.40918 | 108 | 10 | 3,800 | 2 | 3 | SIP>=30 | 3 |
5,243 | 72.422 | 1 | male | 0 | 6 | 540 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 26,938 | 15,409.5234 | 16,714 | 16 | white | 21.097656 | 38 | 0.792969 | 0.724976 | 4 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 6 | 65 | 11.5 | 140 | 16 | 39.09375 | 292 | 1.799805 | 1.099854 | 1.799805 | 137 | 7.259766 | 121 | 14 | 2,850 | null | 0 | no(M2 and SIP pres) | 0 |
5,244 | 70.36298 | 1 | male | 1 | 14 | 14 | COPD | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 50,172 | 29,052.5781 | 27,719 | 31.333328 | white | 18.5 | 36 | 0.820923 | 0.708984 | 1 | 0 | 0 | yes | 0.5 | 0.4 | dnr after sadm | 12 | 65 | 6.5 | 55 | 20 | 36.09375 | 276.1875 | 3.899902 | 0.799927 | 1.199951 | 138 | 7.439453 | 83 | 21 | 2,075 | null | 0 | <2 mo. follow-up | 0 |
5,245 | 65.43195 | 1 | male | 0 | 5 | 181 | Lung Cancer | Cancer | 2 | 15 | >$50k | 0 | 11,205 | 5,668.1016 | 3,621 | 13 | white | 10.798828 | 21 | 0.810913 | 0.593994 | 1 | 1 | 0 | metastatic | null | null | no dnr | 5 | 65 | 14 | 135 | 6 | 38.5 | 185 | null | 0.299988 | 0.899902 | 142 | 7.449219 | 92 | 7 | 3,515 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,246 | 78.47998 | 1 | female | 1 | 13 | 13 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | null | 9 | 36,049 | 21,361.4844 | 20,538 | 32 | white | 25.199219 | 36 | 0.668945 | 0.496948 | 1 | 0 | 0 | no | 0.7 | 0.6 | dnr after sadm | 10 | 99 | 10.699219 | 75 | 22 | 38.09375 | 228.5625 | 3 | 0.399963 | 0.799927 | 142 | 7.479492 | 117 | 5 | null | null | 6 | <2 mo. follow-up | 6 |
5,247 | 77.12 | 1 | male | 0 | 18 | 83 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 9 | 49,281 | 29,451.9375 | 32,611 | 23.333328 | white | 38.898438 | 52 | 0.291992 | 0.181976 | 4 | 0 | 0 | no | 0.5 | 0.35 | no dnr | 18 | 107 | 10 | 109 | 28 | 36.59375 | 176.1875 | 4 | 0.299988 | 0.899902 | 139 | 7.379883 | 132 | 15 | 1,600 | 1 | 1 | no(M2 and SIP pres) | 1 |
5,248 | 57.92999 | 1 | female | 0 | 14 | 572 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 43,351 | 25,587.25 | 27,790 | 21.666656 | white | 24.5 | 40 | 0.780884 | 0.708984 | 1 | 1 | 0 | yes | 0.8 | 0.75 | no dnr | 14 | 73 | 8.199219 | 75 | 0 | 38.09375 | 200 | null | null | 0.899902 | 141 | 7.449219 | 109 | 16 | 3,225 | 1 | 1 | SIP>=30 | 1 |
5,249 | 44.76898 | 0 | female | 0 | 12 | 608 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | >$50k | 9 | 41,805 | 23,602.1875 | 21,833 | 37 | white | 28.597656 | 39 | 0.787964 | 0.718994 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 12 | 74 | 0.699951 | 100 | 32 | 36.59375 | 204.0625 | null | null | 0.799927 | 136 | 7.359375 | 205 | 21 | 4,485 | null | 0 | no(M2 and SIP pres) | 0 |
5,250 | 58.793 | 0 | male | 0 | 81 | 608 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 5 | null | 0 | 264,071 | 151,383.5 | 151,790 | 21.75 | other | 20.398438 | 32 | 0.813965 | 0.751953 | 33 | 0 | 0 | no | null | null | no dnr | 81 | 98 | 0.099991 | 105 | 20 | 38.5 | null | 3.199707 | 0.699951 | 0.699951 | 140 | null | 99 | 6 | 4,625 | null | 1 | adl>=4 (>=5 if sur) | 1 |
5,251 | 52.42999 | 0 | male | 0 | 28 | 608 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | >$50k | 0 | 102,454 | null | null | 29.5 | white | 29.597656 | 55 | 0.665894 | 0.491943 | 1 | 1 | 0 | no | 0.5 | 0.4 | no dnr | 28 | 58 | 19.398438 | 115 | 8 | 40 | 142 | 2 | 0.299988 | 0.799927 | 143 | 7.399414 | 119 | 39 | 1,340 | null | 0 | no(M2 and SIP pres) | 0 |
5,252 | 70.612 | 0 | male | 0 | 22 | 608 | Coma | Coma | 0 | 10 | null | 61 | 48,467 | 28,802.6406 | 31,511 | 24 | black | 20.699219 | 34 | 0.445984 | 0.372986 | 1 | 0 | 0 | no | 0.1 | 0.05 | no dnr | 22 | 79 | 11.199219 | 130 | 25 | 36.19531 | null | 4.199219 | 1.199951 | 1.399902 | 141 | null | 96 | 21 | 2,275 | null | 0 | adl>=4 (>=5 if sur) | 0 |
5,253 | 69.771 | 1 | female | 0 | 9 | 37 | Colon Cancer | Cancer | 1 | 13 | $25-$50k | 0 | 13,072 | 7,609.6094 | 6,418 | 14 | white | 14.699219 | 12 | 0.838989 | 0.645996 | 1 | 0 | 0 | metastatic | 0.5 | 0.2 | no dnr | 9 | 105 | 6.199219 | 130 | 30 | 36.39844 | 53 | 2 | 3.899902 | 0.599976 | 138 | 7.339844 | 305 | 25 | 239 | 0 | 0 | <2 mo. follow-up | 0 |
5,254 | 69.08698 | 1 | female | 1 | 39 | 39 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | null | 0 | 180,614 | 102,454.125 | 100,007 | 31 | white | 23.199219 | 26 | 0.761963 | 0.68689 | 6 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 17 | 112 | 13 | 135 | 24 | 37 | 93.75 | null | 1.599854 | 0.699951 | 140 | 7.389648 | 185 | 16 | 4,860 | null | 6 | <2 mo. follow-up | 6 |
5,255 | 76.54797 | 1 | male | 1 | 26 | 26 | MOSF w/Malig | ARF/MOSF | 0 | 4 | under $11k | 26 | 99,145 | 57,523.125 | 58,555 | 24.5 | white | 25.5 | 25 | 0.422974 | 0.302979 | 14 | 0 | 0 | yes | 0.8 | 0.7 | dnr after sadm | 6 | 102 | 6.099609 | 55 | 24 | 36.09375 | null | null | 3.199707 | 0.799927 | 135 | null | 331 | 11 | null | null | 7 | <2 mo. follow-up | 7 |
5,256 | 61.45697 | 1 | female | 0 | 13 | 524 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 31,807 | 19,082.6562 | 17,561 | 24.5 | white | 14.699219 | 10 | 0.851929 | 0.671997 | 1 | 0 | 0 | metastatic | 0.85 | 0.65 | no dnr | 13 | 105 | 6.5 | 110 | 22 | 36.59375 | 200 | null | 0.299988 | 0.599976 | 141 | 7.289062 | 122 | 5 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,257 | 43.159 | 0 | male | 0 | 68 | 607 | CHF | COPD/CHF/Cirrhosis | 3 | 15 | $11-$25k | 0 | 181,664 | 113,593.125 | 120,379 | 13.75 | black | 21.597656 | 25 | 0.900879 | 0.833984 | 1 | 0 | 0 | no | null | null | no dnr | 68 | 110 | 16.5 | 112 | 32 | 36.39844 | null | 3.299805 | 0.199982 | 0.699951 | 141 | null | 285 | 32 | 2,800 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,258 | 74.83899 | 0 | female | 0 | 7 | 606 | COPD | COPD/CHF/Cirrhosis | 1 | 14 | under $11k | 0 | 13,540 | 8,456.5469 | 7,916 | 9 | white | 19.699219 | 21 | 0.819946 | 0.706909 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 7 | 68 | 14.298828 | 125 | 42 | 39 | 124.48438 | 2.799805 | 0.699951 | 0.899902 | 138 | 7.429688 | 106 | 29 | 1,525 | 1 | 1 | SIP>=30 | 1 |
5,259 | 59.504 | 1 | male | 1 | 15 | 15 | MOSF w/Malig | ARF/MOSF | 3 | 12 | $11-$25k | 44 | 72,035 | 43,440.6875 | 39,870 | 29.666656 | white | 34.09375 | 88 | 0.071991 | 0.025997 | 16 | 1 | 0 | metastatic | 0.5 | 0.5 | dnr after sadm | 2 | 0 | 10.5 | 0 | 0 | 36 | 234.28125 | null | 0.399963 | 0.799927 | 143 | 7.399414 | 133 | 17 | 1,070 | null | 3 | <2 mo. follow-up | 3 |
5,260 | 81.31995 | 1 | male | 0 | 4 | 289 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 6,434 | 3,885.0566 | 2,558 | 20 | white | 26.898438 | 10 | 0.405945 | 0.106995 | 1 | 0 | 0 | metastatic | 0.8 | 0.4 | no dnr | 4 | 72 | 10.798828 | 85 | 7 | 38.59375 | 146.65625 | null | null | 1.099854 | 136 | 7.479492 | 141 | 48 | 1,590 | 1 | 0 | null | 0 |
5,261 | 40.68698 | 0 | male | 0 | 6 | 605 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | $11-$25k | 0 | 8,484 | 5,322.5312 | 4,837 | 19 | black | 14.199219 | 11 | 0.946899 | 0.909912 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 105 | 30.5 | 115 | 32 | 35.59375 | 66 | 2 | null | 5.599609 | 137 | 7.239258 | 259 | 72 | 485 | 0 | null | no(M2 and SIP pres) | 0.494751 |
5,262 | 58.23999 | 0 | female | 0 | 26 | 605 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 0 | 99,840 | 56,244.9062 | 52,594 | 33.75 | white | 30.796875 | 40 | 0.721924 | 0.635986 | 1 | 0 | 0 | no | 0.8 | 0.512 | no dnr | 26 | 58 | 2.5 | 125 | 36 | 40 | 208.5625 | null | 1.099854 | 1.299805 | 150 | 7.399414 | 141 | 27 | 2,890 | null | 0 | no(M2 and SIP pres) | 0 |
5,263 | 70.97894 | 0 | male | 0 | 6 | 605 | CHF | COPD/CHF/Cirrhosis | 3 | 0 | under $11k | 0 | 4,417 | 3,228.3809 | 3,390 | 12 | black | 19.898438 | 24 | 0.844971 | 0.744995 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 96 | 10 | 72 | 16 | 36.79688 | 225.90625 | null | 0.699951 | 0.699951 | 139 | 7.389648 | 100 | 5 | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,264 | 82.54895 | 1 | female | 1 | 9 | 9 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 9 | 12,084 | 7,861.2812 | 8,216 | 12 | white | 26.199219 | 40 | 0.526978 | 0.326965 | 1 | 0 | 0 | yes | 0.05 | 0.05 | dnr after sadm | 2 | 102 | 7.699219 | 125 | 40 | 37.79688 | 328.5625 | null | null | 0.699951 | 137 | 7.369141 | 228 | 26 | 1,770 | 0 | 0 | <2 mo. follow-up | 0 |
5,265 | 64.80194 | 1 | female | 0 | 24 | 560 | MOSF w/Malig | ARF/MOSF | 2 | 15 | null | 0 | 106,845 | 64,932.3125 | 61,270 | 13.333328 | white | 28.398438 | 63 | 0.474976 | 0.355957 | 34 | 0 | 0 | yes | 0.7 | 0.6 | no dnr | 24 | 65 | 15.199219 | 125 | 14 | 39.5 | 132.5 | 2 | 2.099609 | 1.299805 | 136 | 7.389648 | 81 | 12 | 1,750 | 1 | 3 | adl>=4 (>=5 if sur) | 3 |
5,266 | 70.07794 | 1 | male | 0 | 4 | 83 | COPD | COPD/CHF/Cirrhosis | 2 | 8 | null | 9 | null | 2,366.9219 | 2,386 | 9 | white | 21.097656 | 32 | 0.805908 | 0.685913 | 1 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 4 | 100 | 1.299805 | 104 | 22 | 38.39844 | 364 | null | 0.5 | 0.899902 | 137 | 7.399414 | 101 | 10 | 1,775 | null | 7 | null | 7 |
5,267 | 72.12 | 1 | male | 1 | 31 | 31 | MOSF w/Malig | ARF/MOSF | 1 | 7 | $25-$50k | 0 | 172,847 | 98,894.1875 | 95,441 | 42 | black | 36.398438 | 69 | 0.213989 | 0.117996 | 4 | 0 | 0 | metastatic | 0.3 | 0.3 | dnr after sadm | 23 | 113 | 26.5 | 115 | 9 | 36.5 | 275 | null | 2.699707 | 6.5 | 125 | 7.399414 | 354 | 108 | 533 | 0 | 0 | <2 mo. follow-up | 0 |
5,268 | 59.00598 | 1 | male | 0 | 11 | 413 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | >$50k | 37 | 51,587 | 31,702.0469 | 29,248 | 42.5 | other | 37.695313 | 69 | 0.344971 | 0.228973 | 2 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 11 | 58 | 10.398438 | 75 | 16 | 35.09375 | 123.32812 | 2.099609 | 0.599976 | 5 | 133 | 7.419922 | 216 | 98 | 625 | null | 6 | null | 6 |
5,269 | 72.65997 | 1 | female | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 2 | under $11k | 100 | 24,193 | 16,319.5625 | 14,451 | 46 | white | 78.390625 | 70 | 0 | 0 | 2 | 0 | 0 | no | 0.05 | 0 | dnr after sadm | 2 | 96 | 6.399414 | 97 | 20 | 36.59375 | 476.1875 | 3.299805 | 0.899902 | 0.899902 | 137 | 7.5 | 93 | 10 | 900 | null | null | <2 mo. follow-up | 1.823486 |
5,270 | 63.48798 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 0 | 55,969 | 32,768.0938 | 31,940 | 36 | black | 41.195313 | 104 | 0.334961 | 0.219971 | 8 | 0 | 0 | no | 0.1 | 0.5 | dnr after sadm | 5 | 130 | 7.299805 | 130 | 30 | 39.79688 | 296.625 | null | null | 1.899902 | 130 | 7.399414 | 206 | 26 | 2,555 | null | 5 | <2 mo. follow-up | 5 |
5,271 | 55.50699 | 0 | male | 0 | 3 | 599 | CHF | COPD/CHF/Cirrhosis | 3 | 18 | null | 0 | 3,751 | 2,599.6055 | 2,144 | 6 | white | 18.597656 | 20 | 0.897949 | 0.828979 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 3 | 0 | 21.097656 | 0 | 0 | 36.29688 | 53.32812 | 1.299805 | 17.597656 | 3.699707 | 147 | 7.289062 | 7 | 11 | 0 | 0 | null | no(M2 and SIP pres) | 0.494751 |
5,272 | 60.82999 | 0 | male | 0 | 38 | 599 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | $25-$50k | 44 | null | 55,461.4062 | 61,053 | 24.5 | white | 24.796875 | 41 | 0.625 | 0.520996 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 38 | 76 | 5.099609 | 88 | 28 | 36.79688 | null | null | 1.5 | 0.599976 | 127 | null | 184 | 9 | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
5,273 | 79.65796 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 115,444 | 62,643.2812 | 67,554 | 46 | white | 49.59375 | 84 | 0.048996 | 0.014999 | 10 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 4 | 108 | 7.399414 | 125 | 0 | 38.5 | 183.65625 | 3.899902 | 2.699707 | 1.799805 | 140 | 7.5 | 199 | 22 | 3,850 | null | 0 | <2 mo. follow-up | 0 |
5,274 | 33.75198 | 1 | female | 0 | 21 | 47 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | $25-$50k | 0 | 176,006 | 96,187.125 | 99,543 | 34.333313 | white | 28.5 | 85 | 0.779907 | 0.707886 | 49 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 21 | 72 | 7.699219 | 115 | 20 | 37.79688 | 233.3125 | null | null | 0.899902 | 144 | 7.339844 | 133 | 24 | null | null | 6 | <2 mo. follow-up | 6 |
5,275 | 68.07397 | 1 | male | 0 | 27 | 36 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 20 | >$50k | 0 | 83,878 | 52,124.8438 | 55,554 | 21.5 | white | 31.5 | 56 | 0.18399 | 0.051994 | 15 | 0 | 0 | metastatic | 0.5 | 0.15 | dnr after sadm | 6 | 82 | 4.5 | 60 | 24 | 36.59375 | null | null | 0.399963 | 1 | 140 | null | 98 | 12 | null | null | null | <2 mo. follow-up | 3.181641 |
5,276 | 48.33698 | 0 | male | 0 | 4 | 597 | Lung Cancer | Cancer | 2 | 13 | null | 0 | 7,371 | 4,496.9922 | 2,540 | 17 | black | 7.699219 | 12 | 0.870972 | 0.710938 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 4 | 73 | 11.798828 | 75 | 22 | 36.19531 | 390.4375 | null | 0.399963 | 1.299805 | 136 | 7.479492 | 66 | 19 | 2,000 | null | null | SIP>=30 | 1.844482 |
5,277 | 66.784 | 1 | male | 0 | 4 | 155 | Lung Cancer | Cancer | 3 | 13 | >$50k | 0 | 6,887 | 3,874.1602 | 1,958 | 13 | white | 11.898438 | 14 | 0.791992 | 0.56189 | 1 | 1 | 0 | metastatic | null | null | no dnr | 4 | 65 | 10.798828 | 125 | 29 | 36.29688 | 114.28125 | 1.699951 | 0.299988 | 9.099609 | 133 | 7.389648 | 108 | 66 | 220 | null | null | SIP>=30 | 2.168945 |
5,278 | 47.702 | 1 | male | 0 | 7 | 543 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 4 | under $11k | 0 | 5,262 | 3,858.5606 | 3,823 | 2.5 | white | 15.5 | 24 | 0.893921 | 0.821899 | 1 | 1 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 125 | 22.5 | 115 | 36 | 38 | 190 | null | 2.5 | 0.699951 | 142 | 7.389648 | 107 | 19 | 3,215 | 2 | null | adl>=4 (>=5 if sur) | 1.838867 |
5,279 | 68.80499 | 0 | male | 0 | 5 | 595 | Lung Cancer | Cancer | 3 | 12 | $11-$25k | 0 | 7,790 | 4,193.7852 | 2,616 | 14 | white | 12 | 9 | 0.786987 | 0.552979 | 1 | 1 | 0 | metastatic | 1 | 0.9 | no dnr | 5 | 65 | 22.898438 | 115 | 35 | 35.79688 | 47 | 2.199707 | 2.099609 | 4.899414 | 146 | 7.179688 | 224 | 114 | 224 | null | null | no(M2 and SIP pres) | 2.179688 |
5,280 | 75.31799 | 1 | male | 0 | 18 | 19 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 13,355 | 9,905.4141 | 10,761 | 8.666664 | white | 22.699219 | 30 | 0.791992 | 0.665894 | 1 | 1 | 0 | no | null | null | dnr after sadm | 10 | 75 | 10.5 | 100 | 22 | 36 | null | null | 0.899902 | 0.799927 | 134 | null | 330 | 17 | 3,300 | null | null | <2 mo. follow-up | 3.402832 |
5,281 | 72.96594 | 1 | male | 0 | 17 | 236 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | under $11k | 0 | 117,270 | 66,003.5625 | 58,856 | 19.333328 | hispanic | 27.898438 | 43 | 0.593994 | 0.402954 | 27 | 0 | 0 | no | null | null | no dnr | 17 | 127 | 11.5 | 125 | 10 | 38.69531 | 118.32812 | null | null | 1.099854 | 134 | 7.429688 | 168 | 16 | 2,495 | 2 | 0 | no(M2 and SIP pres) | 0 |
5,282 | 73.37396 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 6 | under $11k | 0 | 11,001 | 7,667.4492 | 8,798 | 14 | white | 28.199219 | 30 | 0.702881 | 0.612915 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 77 | 5.099609 | 80 | 20 | 35.89844 | null | null | null | 0.699951 | 137 | null | 93 | 6 | 3,200 | 1 | null | <2 mo. follow-up | 1.166748 |
5,283 | 71.58698 | 1 | male | 0 | 12 | 78 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | under $11k | 9 | 36,480 | 22,031.25 | 20,923 | 20.5 | black | 25.597656 | 44 | 0.697998 | 0.60791 | 3 | 0 | 0 | no | null | null | no dnr | 12 | 69 | 5.399414 | 50 | 16 | 37.69531 | null | null | 0.5 | 0.799927 | 138 | null | 75 | 6 | 1,400 | null | 6 | null | 6 |
5,284 | 58.06198 | 0 | male | 0 | 3 | 592 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | null | null | null | 9 | black | 23.5 | 17 | 0.843994 | 0.743896 | 1 | 0 | 0 | no | 0.85 | 0.8 | no dnr | 3 | 138 | 11.699219 | 145 | 0 | 38.19531 | 190 | null | 0.599976 | 0.699951 | 143 | 7.459961 | 101 | 14 | 1,680 | 0 | 0 | null | 0 |
5,285 | 61.32199 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 81,430 | 45,189.9688 | 42,309 | 47 | black | 34.796875 | 55 | 0.537964 | 0.42395 | 8 | 1 | 0 | no | 0.4 | 0.3 | dnr after sadm | 5 | 67 | 6.299805 | 119 | 28 | 38.89844 | null | 2.5 | 5.599609 | 0.799927 | 137 | null | 80 | 5 | null | null | null | <2 mo. follow-up | 2.124512 |
5,286 | 26.355 | 0 | male | 0 | 27 | 591 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | null | 41,310.8438 | 40,802 | 9.25 | white | 16.699219 | 28 | 0.929932 | 0.903931 | 8 | 0 | 0 | no | 1 | 1 | no dnr | 27 | 75 | 11.5 | 78 | 14 | 36.5 | 328 | 3.099609 | 0.5 | 5.5 | 130 | 7.349609 | 404 | 31 | 20 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,287 | 63.30499 | 0 | female | 0 | 12 | 590 | COPD | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 50,617 | 27,886.4531 | 35,712 | 35.5 | white | 23.199219 | 28 | 0.816895 | 0.702881 | 3 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 12 | 50 | 5.799805 | 165 | 28 | 36.39844 | 116.65625 | 2 | null | 3.5 | 133 | 7.299805 | 322 | 74 | 45 | 0 | 5 | no(M2 and SIP pres) | 5 |
5,288 | 58.056 | 1 | female | 1 | 7 | 7 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 9 | 6,012 | 3,815.5801 | 3,552 | 8 | white | 14.5 | 23 | 0.73999 | 0.474976 | 1 | 0 | 0 | metastatic | 0.2 | 0.05 | dnr after sadm | 2 | 157 | 12.898438 | 135 | 32 | 38.09375 | null | null | null | 0.699951 | 141 | null | 498 | 4 | 1,405 | null | 3 | <2 mo. follow-up | 3 |
5,289 | 34.54898 | 1 | female | 1 | 4 | 4 | Coma | Coma | 0 | null | under $11k | 100 | 21,703 | 13,767.3281 | 12,530 | 36 | other | 51.898438 | 58 | 0.002 | 0 | 1 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 4 | 117 | 10.398438 | 105 | 28 | 36.39844 | 138.75 | null | 0.5 | 1.399902 | 136 | 7.459961 | 142 | 36 | 3,280 | null | 0 | <2 mo. follow-up | 0 |
5,290 | 69.74097 | 1 | female | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | $11-$25k | 89 | 24,106 | 14,195.3359 | 13,228 | 24 | black | 37.195313 | 65 | 0.085999 | 0.032997 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 8 | 112 | 25.796875 | 80 | 14 | 36.5 | 200 | null | null | 1.899902 | 141 | 7.30957 | 196 | 32 | 2,210 | null | 7 | <2 mo. follow-up | 7 |
5,291 | 68.10394 | 1 | male | 0 | 5 | 273 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 10,815 | 5,907.2461 | 4,377 | 13 | white | 13.699219 | 5 | 0.761963 | 0.509888 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 5 | 122 | 8.5 | 105 | 25 | 37.59375 | 220 | 2.799805 | 0.399963 | 1.299805 | 136 | 7.299805 | 187 | 27 | 1,330 | 0 | null | no(M2 and SIP pres) | 0.494751 |
5,292 | 62.51099 | 0 | female | 0 | 5 | 590 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 12,801 | 6,578.5117 | 4,481 | 11 | white | 12.298828 | 12 | 0.793945 | 0.564941 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 5 | 72 | 3.899902 | 68 | 20 | 35.79688 | null | 4 | 0.599976 | 0.799927 | 138 | null | 191 | 23 | 4,475 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,293 | 45.32498 | 1 | female | 0 | 25 | 512 | Coma | Coma | 1 | null | under $11k | 61 | 55,698 | null | null | 22.5 | black | 22.796875 | 20 | 0.625977 | 0.563965 | 1 | 0 | 0 | no | 0.8 | 0.78 | no dnr | 25 | 65 | 7.099609 | 128 | 32 | 36.79688 | 238.09375 | 2.799805 | 0.299988 | 0.699951 | 139 | 7.449219 | 223 | 16 | 1,520 | null | 0 | null | 0 |
5,294 | 62.38199 | 1 | male | 0 | 13 | 44 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 9 | 26,571 | 18,846.5781 | 18,957 | 19.5 | white | 24.199219 | 31 | 0.668945 | 0.495972 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 13 | 38 | 15.298828 | 150 | 24 | 35.69531 | null | null | null | 0.799927 | 135 | null | 111 | 28 | 915 | 0 | null | <2 mo. follow-up | 0.494751 |
5,295 | 41.93799 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 25,122 | 15,689.3438 | 16,556 | 25 | white | 59.695313 | 68 | 0.068985 | 0.023998 | 2 | 0 | 0 | no | null | null | dnr after sadm | 2 | 62 | 17.296875 | 125 | 26 | 38 | 362 | null | 0.299988 | 2 | 136 | 7.439453 | 286 | 35 | 3,140 | null | null | <2 mo. follow-up | 2.249512 |
5,296 | 38.91599 | 1 | female | 0 | 10 | 395 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 9 | 15,182 | 10,071.1641 | 10,648 | 14.5 | black | 23 | 28 | 0.873901 | 0.828979 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 115 | 31.296875 | 145 | 31 | 36.59375 | 246.65625 | 2.5 | 0.899902 | 0.399963 | 131 | 7.40918 | 89 | 5 | 6,820 | 6 | 5 | adl>=4 (>=5 if sur) | 5 |
5,297 | 26.883 | 0 | male | 0 | 16 | 588 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | $11-$25k | 9 | 51,208 | 29,285.9688 | 31,848 | 16.666656 | black | 26 | 24 | 0.861938 | 0.813965 | 2 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 16 | 95 | 30.199219 | 145 | 24 | 38.5 | 236 | 2.399902 | 0.699951 | 1.299805 | 137 | 7.399414 | 94 | 8 | 2,250 | null | 0 | no(M2 and SIP pres) | 0 |
5,298 | 64.59698 | 0 | female | 0 | 47 | 588 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 5 | $11-$25k | 41 | 150,749 | 84,257.9375 | 97,802 | 33.25 | white | 16.398438 | 34 | 0.776978 | 0.704956 | 5 | 0 | 0 | no | 0.5 | 0.35 | dnr after sadm | 13 | 119 | 13.199219 | 130 | 6 | 35.59375 | 340 | 2.299805 | 5.5 | 0.899902 | 137 | 7.469727 | 324 | 38 | 1,335 | null | 1 | null | 1 |
5,299 | 57.547 | 0 | male | 0 | 11 | 588 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 24,415 | 13,932.5469 | 11,493 | 7.5 | white | 12.898438 | 14 | 0.875977 | 0.718994 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 11 | 108 | 11.5 | 125 | 30 | 38 | 250 | null | null | 0.899902 | 142 | 7.449219 | 148 | 28 | 1,175 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,300 | 57.74899 | 1 | male | 1 | 9 | 9 | Lung Cancer | Cancer | 1 | 14 | >$50k | 0 | 9,471 | 5,769.2539 | 6,352 | 12 | white | 27.5 | 22 | 0.468994 | 0.152985 | 1 | 0 | 0 | metastatic | 0.4 | 0.1 | dnr after sadm | 4 | 109 | 8.5 | 84 | 16 | 36.79688 | null | null | 0.399963 | 0.799927 | 134 | null | 69 | 6 | 4,300 | null | 1 | <2 mo. follow-up | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.